Fig. 3. Hemodynamic effects. Group data show pulmonary artery pressure (PAP), arterial pressure (AP), aortic flow, and the ratio of pulmonary over systemic vascular resistance (PVR/SVR) before and after inhalation (  A and  B ) or intravenous (  C ) delivery of milrinone (  filled circles ) or NaCl (  open circles ) in congestive heart failure (CHF) rats (  A and  C ) or sham-operated animals (  B ), respectively. Concentrations for milrinone and NaCl aerosols were 1 mg/ml and 0.9%, respectively. Intravenous doses were 10-μg/kg body weight bolus and 1-μg · kg body weight−1· min−1infusion rate for milrinone and equal volumes for 0.9% NaCl. Data are from n = 11 rats in each group. *  P < 0.05  versus baseline (before). #  P < 0.05  versus NaCl. 

Fig. 3. Hemodynamic effects. Group data show pulmonary artery pressure (PAP), arterial pressure (AP), aortic flow, and the ratio of pulmonary over systemic vascular resistance (PVR/SVR) before and after inhalation (  A and  B ) or intravenous (  C ) delivery of milrinone (  filled circles ) or NaCl (  open circles ) in congestive heart failure (CHF) rats (  A and  C ) or sham-operated animals (  B ), respectively. Concentrations for milrinone and NaCl aerosols were 1 mg/ml and 0.9%, respectively. Intravenous doses were 10-μg/kg body weight bolus and 1-μg · kg body weight−1· min−1infusion rate for milrinone and equal volumes for 0.9% NaCl. Data are from n = 11 rats in each group. *  P < 0.05  versus baseline (before). #  P < 0.05  versus NaCl. 

Close Modal

or Create an Account

Close Modal
Close Modal